Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06170281
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Migraine
- Headache
- Headache Disorders
- Migraine
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Migraine Behavioral Treatment — BEHAVIORALMigraine Behavioral Treatment involving daily activities
Study Details
This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
Key Dates
- Start date
- Dec 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 1, 2028
- Completion
- Dec 1, 2028
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Random - MEparticipants will be randomized to an intervention involving regular mealtime and regular timed exercise
- Active Comparator: Random - MSparticipants will be randomized to an intervention involving regular mealtime and regular sleep
- Active Comparator: Random - SEparticipants will be randomized to an intervention involving regular sleep and regular timed exercise
- Active Comparator: Choice - MEthis arm belongs to participants who choose the intervention involving regular mealtime and regular timed exercise
- Active Comparator: Choice - MSthis arm belongs to participants who choose the intervention involving regular mealtime and regular sleep
- Active Comparator: Choice - SEthis arm belongs to participants who choose the intervention involving regular sleep and regular timed exercise
Primary Outcome Measure
Feasibility in terms of recruitment and adherence rates [ Time Frame: 12 weeks ]
Central Contacts
- Yohannes W. Woldeamanuel, MD480-342-1385
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 |
Find similar trials in Phoenix, AZ
By condition
By specialty
By research site
Related Studies
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama
- Determining the Utility of a Behavioral Intervention in Chronic MigraineRecruiting · Mayo Clinic · Phoenix, Arizona
- Responding With Evidence and Access for Childhood HeadachesRecruiting · Children's Hospital Medical Center, Cincinnati · Birmingham, Alabama
- Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive MedicationsPHASE4 · Recruiting · Mayo Clinic · Phoenix, Arizona